Gestational diabetes mellitus in the COVID ‐19 pandemic: A retrospective study from Hangzhou, China
| العنوان: | Gestational diabetes mellitus in the |
|---|---|
| المؤلفون: | Binbin Yin, Kaiqi Wu, Lingwei Hu, Wanlu Zheng, Yidan Zheng, Xiuzhi Duan, Bo Zhu |
| المصدر: | Journal of Diabetes. 14:711-720 |
| بيانات النشر: | Wiley, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | China, Diabetes, Gestational, Pregnancy, Risk Factors, Endocrinology, Diabetes and Metabolism, Pregnancy Outcome, COVID-19, Humans, Female, Pandemics, Retrospective Studies |
| الوصف: | Our study aimed to investigate changes in the prevalence of gestational diabetes mellitus (GDM) in the COVID-19 pandemic and postpandemic era and the risk of adverse pregnancy outcomes in pregnant women diagnosed with GDM during the blockade period.First, we investigated changes in the prevalence of GDM and the population undergoing oral glucose tolerance tests (OGTT) after the COVID-19 pandemic. We then collected clinical information from pregnant women diagnosed with GDM to explore the risk of adverse pregnancy outcomes in pregnant women with GDM during the COVID-19 pandemic.After the COVID-19 pandemic, the proportion of pregnant women in the total number of outpatient OGTT tests decreased yearly. The ratio was 81.30%, 79.71%, and 75.48% from 2019 to 2021, respectively, with the highest proportion of pregnant women in February 2020 (92.03%). The prevalence of GDM was higher in March 2020 compared to the same period in 2019. However, from 2019 to 2021, the prevalence decreased year by year with 21.46%, 19.81%, and 18.48%, respectively. The risk of adverse pregnancy outcomes for pregnant women diagnosed with GDM during the most severe period of the COVID-19 pandemic did not differ from before the COVID-19 pandemic.After the COVID-19 pandemic, the prevalence of GDM increased during the most severe period of the epidemic, but the overall prevalence of GDM decreased year by year. In addition, the pandemic did not change the risk of adverse pregnancy outcomes in pregnant women with GDM.目的: 我们的研究旨在调查 COVID-19 大流行和大流行后时代妊娠糖尿病(GDM)患病率的变化, 以及在封锁期间诊断为GDM的孕妇发生不良妊娠结局的风险。 方法: 首先, 我们调查了 COVID-19 大流行后 GDM 患病率和接受口服葡萄糖耐量试验 (OGTT) 的人群的变化。然后, 我们收集了被诊断患有 GDM 的孕妇的临床信息, 以探讨在 COVID-19 大流行期间患有 GDM 的孕妇出现不良妊娠结局的风险。 结果: 在 COVID-19 大流行之后, 孕妇在门诊 OGTT 检测总数中的比例逐年下降。 2019年至2021年该比例分别为81.30%、79.71%和75.48%, 2020年2月孕妇比例最高(92.03%)。 2020年3月GDM患病率高于2019年同期, 但2019-2021年患病率逐年下降, 分别为21.46%、19.81%和18.48%。在 COVID-19 大流行最严重时期诊断为 GDM 的孕妇的不良妊娠结局风险与 COVID19 大流行之前没有差异。 结论: COVID-19大流行后, GDM患病率在疫情最严重时期呈上升趋势, 但GDM总体患病率逐年下降。此外, 大流行并未改变 GDM 孕妇不良妊娠结局的风险。. |
| تدمد: | 1753-0407 1753-0393 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cb14e9f167a438a741bf643b897a97a https://doi.org/10.1111/1753-0407.13324 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....9cb14e9f167a438a741bf643b897a97a |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 17530407 17530393 |
|---|